FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076245468> ?p ?o ?g. }

• W2076245468 endingPage "5" @default.
• W2076245468 startingPage "1" @default.
• W2076245468 abstract "Free AccessEvidence for Pharmacotherapy of Posttraumatic Stress DisorderGareth SmithGareth SmithSearch for more papers by this authorPublished Online:June 2005https://doi.org/10.1521/capn.8.8.1.27930PDFPDF PLUS ShareShare onFacebookTwitterLinkedInRedditEmail ToolsAdd to favoritesDownload CitationsTrack Citations AboutReferencesBaker , D., Diamond, B., & Gillette, G., et al. (1995). A double-blind randomized placebo-controlled multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology, 122, 386–9. Crossref, Google ScholarBallenger , J., Davidson, J., & Lecrubier, Y., et al. (2000). Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry, 61, 60–6. Google ScholarBrady , K., Killeen, T., & Brewerton, T., et al. (2000). Comorbidity of psychiatric disorders and posttraumatic stress disorder. J Clin Psychiatry, 61(7), 22–32. Google ScholarBrady , K., Pearlstein, T., & Asnis, G., et al. (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. JAMA, 283, 1837–44. Crossref, Google ScholarBraun , P., Greenberg, D., & Dasberg, H., et al. (1990). Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry, 51, 236–8. Google ScholarConnor , K. & Davidson, J. (2001). Sprint: A brief global assessment of post-traumatic stress disorder. Int Clin Psychopharmacol, 16, 279–84. Crossref, Google ScholarConnor , K., Sutherland, S., & Tupler, L., et al. (1999). Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. Brit J Psychiatry, 175, 17–22. Crossref, Google ScholarDavidson , J., Hughes, D., & Blazer, D. G., et al. (1991).Posttraumatic stress disorder in the community: an epidemiological study. Psychol Med, 21, 713–721. Crossref, Google ScholarDavidson , J., Kudler, H., & Smith, R., et al. (1990). Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry, 47, 259–66. Crossref, Google ScholarDavidson , J., Pearlstein, T., & Londborg, P., et al. (2001). Efficacy of sertraline in preventing relapse of posttraumatic stress disorder with depression symptoms. Am J Psychiatry, 158, 1974–81. Crossref, Google ScholarDavidson , J., Rothbaum, B., & van der Kolk, B., et al. (2001). Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry, 58, 485–92. Crossref, Google ScholarHertzberg , M., Butterfield, M., & Feldman, M., et al. (1999). A preliminary study of lamotrigne for the treatment of posttraumatic stress disorder. Biol Psychiatry, 45, 1226–9. Crossref, Google ScholarHertzberg , M., Feldman, M., & Beckham, J. (2000). Lack of efficacy for fluoxetine in PTSD: A placebo controlled trial in combat veterans. Ann Clin Psychiatry, 12, 101–5. Crossref, Google ScholarHidalgo , R. & Davidson, J., et al. (2000). Posttraumatic stress disorder: Epidemiology and health-related considerations. J Clin Psychiatry, 61, 5–13. Google ScholarKaplan , Z., Amir, M., & Swartz, M., et al. (1996). Inositol treatment of post-traumatic stress disorder. Anxiety, 2, 51–2. Crossref, Google ScholarKatz , R., Lott, M., & Arbus, P., et al. (1994). Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety, 1, 169–74. Crossref, Google ScholarKessler , R., Sonnega, A., & Bromet, E., et al. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry, 52, 1048–60. Crossref, Google ScholarKosten , T., Frank, J., & Dan, E., et al. (1991). Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis, 179, 366–370. Crossref, Google ScholarKrakow , B., Hollifield, M., & Warner, T. D. (2000). Placebo effect in posttraumatic stress disorders. JAMA, 284, 563–4. Crossref, Google ScholarLipper , S., Davidson, J. R., & Gardy, T. A. (1986). Preliminary study of carbamazepine in posttraumatic stress disorder. Psychosomatics, 12, 849–54. Crossref, Google ScholarLondberg , P., Hegel, M., & Goldstein, S., et al. (2001). Sertraline treatment of posttraumatic stress disorder: Results of 24 weeks of open-label continuation treatment. J Clin Psychiatry, 62, 325–31. Crossref, Google ScholarMarshall R., Beebe K., & Oldham M., et al. (2001). Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed dose, placebo-controlled study. Am J Psychiatry, 158, 1982–8. Crossref, Google ScholarMartenyi , F., Brown, E., & Zhang, H., et al. (2002). Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry, 63, 199–206. Crossref, Google ScholarPitman , R., Sanders, K., & Zusman, R., et al. (2002). Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry, 51, 189–92. Crossref, Google ScholarReist , C., Kauffman, C., & Haier, R., et al. (1989). A controlled trial of desipraminein 18 men with posttraumatic stress disorder. Am J Psychiatry, 146, 513–6. Crossref, Google ScholarShetatzky , M., Greenberg, D., & Lerer, B. (1987). A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatric Research, 24, 149–55. Crossref, Google ScholarTucker , P., Zaninelli, R. , & Yehuda, R., et al. (2001). Paroxetine in the treatment of chronic posttraumatic stress disorder: Results of a placebo controlled, flexible dosage trial. J Clin Psychiatry, 62, 860–8. Crossref, Google Scholarvan der Kolk , B., Dreyfuss, D., & Michaels, M., et al. (1994). Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry, 55, 517–22. Google ScholarZohar , J., Amital, D., & Miodownik, C., et al. (2002). Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol., 22, 190–5. Crossref, Google Scholar Next article FiguresReferencesRelatedDetails Volume 8Issue 8Dec 2003 Information© The Guilford PressPDF download" @default.
• W2076245468 created "2016-06-24" @default.
• W2076245468 creator A5029751538 @default.
• W2076245468 date "2003-12-01" @default.
• W2076245468 modified "2023-09-25" @default.
• W2076245468 title "Evidence for Pharmacotherapy of Posttraumatic Stress Disorder" @default.
• W2076245468 cites W154801688 @default.
• W2076245468 cites W1575050286 @default.
• W2076245468 cites W1981149786 @default.
• W2076245468 cites W1981269300 @default.
• W2076245468 cites W2003662114 @default.
• W2076245468 cites W2006677106 @default.
• W2076245468 cites W2020176867 @default.
• W2076245468 cites W2020726187 @default.
• W2076245468 cites W2026396276 @default.
• W2076245468 cites W2035683658 @default.
• W2076245468 cites W2039284835 @default.
• W2076245468 cites W2040626393 @default.
• W2076245468 cites W2059468663 @default.
• W2076245468 cites W2081065660 @default.
• W2076245468 cites W2085936773 @default.
• W2076245468 cites W2091136922 @default.
• W2076245468 cites W2102215436 @default.
• W2076245468 cites W2112288335 @default.
• W2076245468 cites W2114214919 @default.
• W2076245468 cites W2118542639 @default.
• W2076245468 cites W2119723109 @default.
• W2076245468 cites W2126659959 @default.
• W2076245468 cites W2160157454 @default.
• W2076245468 cites W4245295585 @default.
• W2076245468 doi "https://doi.org/10.1521/capn.8.8.1.27930" @default.
• W2076245468 hasPublicationYear "2003" @default.
• W2076245468 type Work @default.
• W2076245468 sameAs 2076245468 @default.
• W2076245468 citedByCount "0" @default.
• W2076245468 crossrefType "journal-article" @default.
• W2076245468 hasAuthorship W2076245468A5029751538 @default.
• W2076245468 hasConcept C118552586 @default.
• W2076245468 hasConcept C15744967 @default.
• W2076245468 hasConcept C2777669559 @default.
• W2076245468 hasConcept C2777828372 @default.
• W2076245468 hasConcept C2779177272 @default.
• W2076245468 hasConcept C2991847609 @default.
• W2076245468 hasConcept C558461103 @default.
• W2076245468 hasConcept C71924100 @default.
• W2076245468 hasConceptScore W2076245468C118552586 @default.
• W2076245468 hasConceptScore W2076245468C15744967 @default.
• W2076245468 hasConceptScore W2076245468C2777669559 @default.
• W2076245468 hasConceptScore W2076245468C2777828372 @default.
• W2076245468 hasConceptScore W2076245468C2779177272 @default.
• W2076245468 hasConceptScore W2076245468C2991847609 @default.
• W2076245468 hasConceptScore W2076245468C558461103 @default.
• W2076245468 hasConceptScore W2076245468C71924100 @default.
• W2076245468 hasIssue "8" @default.
• W2076245468 hasLocation W20762454681 @default.
• W2076245468 hasOpenAccess W2076245468 @default.
• W2076245468 hasPrimaryLocation W20762454681 @default.
• W2076245468 hasRelatedWork W2053117573 @default.
• W2076245468 hasRelatedWork W2069052613 @default.
• W2076245468 hasRelatedWork W2078641702 @default.
• W2076245468 hasRelatedWork W2117421705 @default.
• W2076245468 hasRelatedWork W2205705782 @default.
• W2076245468 hasRelatedWork W2305187330 @default.
• W2076245468 hasRelatedWork W2338332083 @default.
• W2076245468 hasRelatedWork W2737394482 @default.
• W2076245468 hasRelatedWork W4226390804 @default.
• W2076245468 hasRelatedWork W4251297200 @default.
• W2076245468 hasVolume "8" @default.
• W2076245468 isParatext "false" @default.
• W2076245468 isRetracted "false" @default.
• W2076245468 magId "2076245468" @default.
• W2076245468 workType "article" @default.